Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation

Neuro Oncol. 2021 Aug 2;23(8):1408-1409. doi: 10.1093/neuonc/noab097.
No abstract available

Publication types

  • Comment

MeSH terms

  • Glioma* / diagnostic imaging
  • Glioma* / radiotherapy
  • Humans
  • Positron-Emission Tomography

Associated data

  • ClinicalTrials.gov/NCT03926507
  • ClinicalTrials.gov/NCT04111588
  • ClinicalTrials.gov/NCT03409549
  • ClinicalTrials.gov/NCT04689048
  • ClinicalTrials.gov/NCT03990285
  • ClinicalTrials.gov/NCT03925675
  • ClinicalTrials.gov/NCT04114370
  • ClinicalTrials.gov/NCT03930173
  • ClinicalTrials.gov/NCT04462419
  • ClinicalTrials.gov/NCT04410133
  • ClinicalTrials.gov/NCT04410367